Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lecithin Found to Help Modulate Lipid Metabolism

By LabMedica International staff writers
Posted on 12 Aug 2009
An endogenous phospholipid and food additive from the lecithin family has been found to activate peroxisome proliferator-activated receptors (PPAR), a class of intracellular receptors that modulate carbohydrate and fat metabolism and adipose tissue differentiation. More...
Activating PPARs induces the transcription of a number of genes that facilitate lipid metabolism.

Investigators from Washington University School of Medicine (St. Louis, MO, USA) genetically engineered a line of mice to lack the gene for the enzyme fatty acid synthase (FAS). Results published in the July 30, 2009, online issue of the journal Cell revealed that these mice had lower fasting insulin levels than normal animals and were prone to develop fatty liver disease. These were the same indications that coincided with impaired PPAR-alpha expression.

While it was known that fibrate drugs could activate PPAR-alpha and restore normal lipid metabolism, the investigators sought an endogenous ligand that could perform the same function. To this end, they used mass spectroscopy and gene expression analysis to demonstrate that the lecithin component phosphatidylcholine (1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine) could bind to and activate PPAR-alpha. This finding was confirmed by showing that "knockdown” of the Cept1 gene, required for phosphatidylcholine synthesis, suppressed PPAR-alpha-dependent gene expression.

"To our surprise, animals missing fatty acid synthase in the liver were just like animals that could not make PPAR-alpha. They had lower fasting insulin levels, and they were prone to develop fatty liver disease,” explained senior author Dr. Clay F. Semenkovich, professor of endocrinology, metabolism, and lipid research at Washington University School of Medicine. "When we gave the animals fibrate drugs that activated PPAR-alpha, the mice returned to normal, leading us to suspect that fatty acid synthase also was involved in the activation of PPAR-alpha. Although we knew that fibrate drugs would regulate PPAR-alpha, we also knew that our ability to regulate the metabolism of fats and sugars was in place long before humans started making drugs. But until now, no one had identified how it worked.”

Related Links:
Washington University School of Medicine



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.